INS and obesity due to melanocortin 4 receptor deficiency: First, the prevention of obesity/lowering fat mass, particularly visceral fat [5–8], reductions in glucose and insulin levels improving insulin sensitivity [9–12], a reduction in oxidative stress and/or increase in antioxidant defense mechanisms [13–16], and a reduction in body temperature [17].